SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169245-20-000053
Filing Date
2020-05-27
Accepted
2020-05-27 16:11:13
Documents
3
Period of Report
2020-05-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kxvangardstudy.htm 8-K 35401
2 EX-99.1 ex991-vangardstudy.htm EX-99.1 19367
3 phasebio2020logo1.jpg GRAPHIC 27705
  Complete submission text file 0001169245-20-000053.txt   94357
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 20915330
SIC: 2834 Pharmaceutical Preparations